Choosing Between Visium and MERFISH for Your Spatial Transcriptomics Study: A Decision Guide Based on Resolution, Throughput, and Data Analysis

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-20

Key Takeaways

• Visium offers transcriptome-wide gene coverage at 55-micrometer spot resolution, suitable for discovery-oriented studies and identifying broad spatial domains, but requires computational deconvolution for cell-type assignment.
• MERFISH provides single-molecule, subcellular resolution for a preselected gene panel, enabling precise cell typing and analysis of subcellular RNA localization, but is limited by panel size and requires prior knowledge of target genes.
• Visium's workflow is sequencing-based and amenable to standard bioinformatics tools adapted for spatial data, with moderate data volume and computational requirements suitable for typical workstations.
• MERFISH involves complex image processing and decoding pipelines, generating large image datasets that demand high-performance computing infrastructure, with analysis resembling single-cell RNA sequencing after transcript assignment.
• FFPE tissue compatibility is a significant advantage for Visium, whereas MERFISH is primarily optimized for fresh frozen tissue, influencing sample selection based on preservation methods.
• Statistical power planning tools like PoweREST are available for Visium to optimize experimental design and resource allocation, while MERFISH power calculations are more complex and often rely on pilot data and custom approaches.

Spatial transcriptomics links gene expression to tissue architecture, but platform selection determines which biological questions can be answered. This guide compares 10x Visium and MERFISH across resolution, gene throughput, and analytical complexity, providing concrete criteria for matching platform capabilities to experimental objectives. If you are a researcher planning a spatial transcriptomics experiment, you face a decision between two fundamentally different technologies. Visium captures transcriptome-wide expression across 55 micrometer spots, while MERFISH images individual RNA molecules at subcellular resolution but measures a preselected gene panel. Your choice affects the data you generate, the computational tools you need, and the statistical approaches available to you.

Scope and Reader Context

This article serves biology students, researchers, laboratory professionals, and life-science practitioners who need to select a spatial transcriptomics platform but are confused by trade-offs in resolution, gene coverage, and analytical complexity. The structured comparison provided here helps you match platform to biological question by examining data inputs, workflow choices, controls, quality checks, reproducibility, interpretation limits, reporting, and practical decision criteria. The decision framework applies to both new investigators planning their first spatial experiment and experienced researchers transitioning from bulk or single-cell approaches.

Core Principles of Spatial Transcriptomics Platforms

Spatial transcriptomics technologies differ fundamentally in how they assign gene expression measurements to physical locations within a tissue section. Understanding these differences is essential before comparing specific platforms, because the measurement principle determines every downstream analysis choice.

How Visium Works

Visium uses a slide with spatially barcoded capture probes arranged in 55 micrometer diameter spots. Tissue sections are placed on the slide, permeabilized, and mRNA diffuses to the capture probes beneath. Each spot captures mRNA from multiple cells, producing a mixed expression profile per spot. The spatial barcode allows you to map each spot back to its physical position on the tissue section. Because the capture probes carry poly-dT sequences, Visium captures polyadenylated mRNA across the entire transcriptome without preselection. This unbiased capture mechanism means you do not need to know which genes matter before running the experiment, making Visium suitable for discovery-oriented studies.

How MERFISH Works

MERFISH uses sequential hybridization of fluorescently labeled probes to image individual RNA molecules directly in the tissue. Each gene in the panel is assigned a unique barcode composed of combinations of fluorescent dyes. After each hybridization round, the tissue is imaged, and the barcodes are decoded to identify individual transcripts and their subcellular positions. MERFISH achieves single-molecule resolution, meaning you can count individual RNA molecules within single cells. However, the gene panel must be designed before the experiment, and the number of genes is limited by the number of available barcode combinations. This requirement for prior knowledge shapes the entire experimental planning process.

The Resolution Tradeoff

The most consequential difference between these platforms is spatial resolution. Visium spots are 55 micrometers in diameter, which typically contains 1 to 10 cells depending on tissue type. This means each measurement is a mixture of cell types, and you cannot assign expression to individual cells without computational deconvolution. MERFISH resolves individual transcripts, allowing you to segment cells based on membrane markers or nuclear stains and assign RNA molecules to specific cells. This single-cell resolution is critical for questions about cell-to-cell variation, ligand-receptor interactions between adjacent cells, and subcellular RNA localization. The resolution difference is also a technical detail, it determines whether your data can support claims about individual cell behavior or only about regional tissue patterns.

The Gene Coverage Tradeoff

Visium captures the full transcriptome, typically detecting 2,000 to 5,000 genes per spot depending on tissue quality and sequencing depth. This unbiased approach is valuable for discovery studies where you do not know which genes matter. MERFISH measures a panel of 100 to 500 genes in standard configurations, with newer panels reaching several thousand genes. The panel design requires prior knowledge of relevant genes, making MERFISH more suitable for hypothesis-driven studies where you already know the key markers and pathways. The gene coverage tradeoff interacts with the resolution tradeoff: you can have single-cell resolution with limited genes, or transcriptome-wide coverage with mixed-cell resolution, but not both simultaneously with these two platforms.

At a Glance: Platform Comparison Table

Practical Workflow Comparison

The experimental workflow differs substantially between platforms, affecting your timeline, equipment needs, and personnel training. Understanding these workflow differences before committing to a platform can prevent costly delays and resource mismatches.

Visium Workflow

The Visium workflow begins with tissue sectioning onto the capture slide. You then perform fixation, staining, and imaging to record tissue morphology. Permeabilization time must be optimized for each tissue type to maximize mRNA capture while minimizing diffusion. After cDNA synthesis and library preparation, you sequence the library and process the data through a pipeline that aligns reads to the transcriptome and assigns them to spatial barcodes. The sequencing step requires access to a high-throughput sequencer, and the data analysis uses standard bioinformatics tools adapted for spatial data. The workflow is linear and well documented, with established protocols available from the vendor and in the literature.

MERFISH Workflow

The MERFISH workflow requires a fluorescence microscope equipped for sequential imaging. You design and synthesize the gene panel probes, hybridize them to the tissue, and perform multiple rounds of imaging. Each round produces images across multiple fluorescence channels, and the decoding algorithm converts the image stack into transcript coordinates. The image data are large, often exceeding several terabytes per experiment, and require substantial storage and computing resources. Cell segmentation uses nuclear stains and membrane markers to define cell boundaries, and transcript counts are assigned to cells based on their coordinates. The workflow has more steps that require optimization, and each step can introduce artifacts that propagate through the analysis.

Time and Resource Considerations

Visium experiments typically take one to two weeks from tissue sectioning to sequencing, followed by several days of data analysis. The main equipment requirements are a cryostat, a sequencing facility, and a standard bioinformatics workstation. MERFISH experiments require a specialized imaging system, probe synthesis capabilities, and significant computational infrastructure for image processing. The imaging itself can take several days per tissue section, and the data analysis pipeline is more complex than standard sequencing-based approaches. When planning your experiment, consider also the direct costs but also the opportunity cost of instrument time and the availability of specialized personnel.

Data Analysis Requirements

The analytical approaches for Visium and MERFISH differ in ways that affect your bioinformatics capacity and the tools you will need. These differences extend beyond the initial processing steps and influence the entire downstream analysis strategy.

Visium Data Analysis

Visium data analysis starts with raw sequencing reads that must be aligned to the reference genome and assigned to spatial barcodes. The output is a count matrix with spots as rows and genes as columns, similar to single-cell RNA sequencing data but with spatial coordinates attached. Standard analysis includes quality control to remove low-quality spots, normalization, dimensionality reduction, clustering to identify spatial domains, and differential expression testing between conditions.

Dimensionality reduction methods designed for spatial data can improve domain detection. Randomized Spatial PCA (RASP) is a spatially aware dimensionality reduction method that scales to datasets with over 100,000 locations and supports integration of non-transcriptomic covariates. RASP reconstructs denoised, spatially smoothed gene expression values and produces principal components that can be clustered to identify spatial domains. Benchmarks comparing RASP to methods including BASS, GraphST, SEDR, SpatialPCA, STAGATE, and CellCharter across Visium, Stereo-Seq, MERFISH, and Xenium datasets showed comparable or superior accuracy in tissue-domain detection with substantial improvements in computational speed. This speed makes it practical to explore multiple spatial-smoothing parameters, allowing you to fine-tune the balance between resolution and noise suppression.

For multi-slice studies, joint analysis across adjacent or replicated sections requires specialized tools. JADE is a framework that simultaneously learns spatial alignments and shared low-dimensional embeddings across tissue slices. It uses attention mechanisms to weight the importance of different embedding dimensions, focusing on alignment-relevant features while suppressing noise. JADE demonstrated improved alignment and embedding performance compared to existing methods on Visium human dorsolateral prefrontal cortex data and Stereo-seq axolotl brain data. MaskGraphene is another integration approach that uses graph neural networks with masked self-supervised learning and cluster-wise local alignment to produce joint embeddings with high geometric fidelity across slices and conditions.

Statistical power planning is an important but often overlooked step. PoweREST is a power estimation tool designed for differential gene expression detection with Visium data. It supports power calculations both before experiments and after preliminary data collection, and it includes a web application for interactive calculation and visualization. Using PoweREST before committing resources to a Visium experiment can help you determine the number of sections or spots needed to detect biologically meaningful expression differences between conditions.

MERFISH Data Analysis

MERFISH data analysis begins with image processing to decode the fluorescence barcodes into transcript identities and coordinates. This step requires specialized software and substantial computational resources. After decoding, you segment cells using nuclear and membrane markers, assign transcripts to cells, and generate a cell-by-gene count matrix. Subsequent analysis resembles single-cell RNA sequencing analysis, including quality control, normalization, clustering, and cell type identification.

The high resolution of MERFISH data enables analyses that are not possible with Visium. You can examine subcellular RNA localization, quantify cell-to-cell variability in expression, and identify rare cell populations based on combinations of markers. However, the panel design limits your analysis to the genes you chose, and you cannot discover new markers or pathways without designing a new panel. This limitation shapes the types of conclusions you can draw and the follow-up experiments you can plan.

Computational Infrastructure Requirements

Visium data analysis can be performed on a standard workstation with 16 to 32 gigabytes of RAM, though larger datasets benefit from more memory. The analysis tools are available through Bioconductor packages, which provide documented workflows for spatial transcriptomics analysis. Bioconductor offers official package documentation and reproducible analysis workflows that can help you implement standard pipelines.

MERFISH data analysis requires substantially more computational resources. The raw image data can exceed several terabytes, requiring high-capacity storage and high-performance computing for image processing. The decoding algorithms are computationally intensive, and cell segmentation adds additional processing time. If your institution lacks high-performance computing infrastructure, MERFISH may not be practical regardless of its biological advantages.

Training resources are available for both platforms. The Galaxy Training Network provides accessible workflow tutorials that can help you learn spatial transcriptomics analysis without extensive programming experience. The Carpentries offers foundational computing and data skills, including shell, Git, and programming training that are useful for managing large datasets and reproducible workflows. EMBL-EBI Training provides learning pathways for bioinformatics data resources and practical analysis education.

Matching Platform to Biological Question

The choice between Visium and MERFISH should be driven by your biological question, not by platform popularity or convenience. The decision framework below organizes the key considerations by research objective.

Questions That Favor Visium

Visium is the better choice when you need unbiased transcriptome-wide coverage. If you are studying a tissue or condition where the relevant genes are unknown, or if you want to discover new markers or pathways, Visium captures the full transcriptome without preselection. This makes it suitable for tissue atlas projects, exploratory studies of disease mechanisms, and differential expression analysis between conditions.

Visium is also more practical for studies requiring multiple biological replicates. The cost per section is lower than MERFISH, and the analysis pipeline is more established. PoweREST can help you plan the number of sections needed for adequate statistical power, which is important for detecting modest expression differences between conditions.

For studies of tissue-level architecture, such as identifying anatomical regions or disease-associated niches, Visium spot resolution is often sufficient. Spatial domain detection methods like RASP can identify tissue regions based on smoothed expression patterns, and the 55 micrometer resolution captures regional differences without needing single-cell detail.

Questions That Favor MERFISH

MERFISH is the better choice when you need single-cell resolution and know which genes to measure. If your question involves cell type identification in complex tissues, cell-to-cell communication, or spatial organization of specific cell populations, MERFISH provides direct single-cell measurements without computational deconvolution.

MERFISH is particularly valuable for studying subcellular RNA localization. The single-molecule resolution allows you to determine whether specific transcripts are enriched in particular cellular compartments, which is impossible with Visium spot measurements. This capability is relevant for understanding mRNA trafficking, local translation, and cellular polarity.

For studies of rare cell populations, MERFISH can identify cells based on combinations of markers with single-cell precision. The imaging approach also allows you to correlate gene expression with morphological features visible in the tissue, providing additional context for interpreting expression patterns.

Questions Where Either Platform Works

Some biological questions can be addressed with either platform, and the choice depends on practical considerations. For identifying spatial domains in tissues with clear anatomical structure, both Visium and MERFISH can produce meaningful results. The choice may depend on whether you need transcriptome-wide coverage or single-cell resolution, and on your computational capacity.

For studying cell-cell interactions, both platforms can identify adjacent cell populations and infer potential ligand-receptor pairs. Visium requires deconvolution to estimate cell type proportions per spot, while MERFISH provides direct cell identities. The choice depends on whether you need genome-wide ligand and receptor expression or can work with a targeted panel.

Sample Type and Quality Considerations

Your sample type may restrict your platform options, and sample quality affects data quality on both platforms. Evaluating sample compatibility early in the planning process prevents wasted effort on incompatible combinations.

Fresh Frozen Tissue

Both Visium and MERFISH work with fresh frozen tissue sections. Tissue preservation and sectioning quality are critical for both platforms. For Visium, the permeabilization time must be optimized to release mRNA from the tissue while preventing diffusion across spots. For MERFISH, tissue autofluorescence can interfere with signal detection, and fixation conditions affect probe penetration and hybridization efficiency.

FFPE Tissue

Visium supports formalin-fixed paraffin-embedded tissue sections, which is important for clinical samples and archival specimens. The FFPE protocol uses probe-based capture that is compatible with cross-linked RNA. MERFISH is primarily optimized for fresh frozen tissue, and FFPE compatibility is limited. If your samples are FFPE, Visium is the practical choice.

Tissue Morphology

Tissues with high autofluorescence, such as those containing red blood cells or lipofuscin, can interfere with MERFISH imaging. Visium is less affected by autofluorescence because the readout is sequencing-based. Dense tissues with high cell density may benefit from MERFISH resolution, while tissues with diffuse expression patterns may be adequately captured by Visium spots.

Quality Control and Quality Checks

Both platforms require rigorous quality control to ensure reliable biological conclusions. The specific metrics differ, but the underlying principle is the same: identify and document technical artifacts before interpreting biological patterns.

Visium Quality Control

Visium quality control begins with assessing sequencing metrics, including read depth per spot, fraction of reads mapped to the transcriptome, and fraction of reads assigned to spatial barcodes. Low-quality spots with few detected genes or high mitochondrial content should be flagged and potentially excluded. Spatial artifacts, such as tissue folding or air bubbles under the capture area, can create regions with no signal and should be documented.

After initial quality control, you should assess whether the detected genes match the expected biology of your tissue. Known cell type markers should show appropriate spatial patterns. If markers are absent or mislocalized, this may indicate permeabilization problems, tissue degradation, or sequencing issues.

MERFISH Quality Control

MERFISH quality control involves assessing decoding accuracy, detection efficiency, and segmentation quality. The decoding algorithm assigns barcodes to transcripts, and you should evaluate the fraction of decoded transcripts that match expected barcode combinations. High background fluorescence can reduce decoding accuracy, and you may need to adjust thresholds.

Detection efficiency is assessed by comparing detected transcript counts to expected expression levels based on independent measurements. If your panel includes genes with known expression levels, you can use these as internal controls. Segmentation quality affects cell assignment, and you should visually inspect segmentation results to ensure cell boundaries are accurate.

Reproducibility Checks

For both platforms, reproducibility across technical replicates is essential. If you run the same tissue section twice or adjacent sections from the same block, the spatial expression patterns should be consistent. Batch effects can arise from differences in sample processing, sequencing runs, or imaging sessions, and you should plan for batch correction in your analysis.

The nf-core documentation provides community standards for reproducible bioinformatics pipelines, which can help you implement consistent analysis workflows. Using version-controlled pipelines and documenting parameter choices supports reproducibility across experiments and laboratories.

Common Failure Patterns and Troubleshooting

Understanding common failure modes can help you avoid costly mistakes and interpret problematic data. The patterns below are organized by platform and by analysis stage.

Visium Failure Patterns

Low RNA capture is a common Visium failure, resulting in few detected genes per spot. This can arise from over-permeabilization that degrades RNA, under-permeabilization that prevents mRNA release, or poor tissue quality. Optimization experiments using a range of permeabilization times are essential for each tissue type.

Spot misalignment occurs when the tissue morphology image does not align with the spatial barcode positions. This can happen if the tissue shifts during processing or if the imaging and sequencing data are not properly registered. Careful imaging and alignment verification are necessary to avoid assigning expression to incorrect locations.

High background or ambient RNA can obscure spatial patterns. This is more common in tissues with high RNA content or when permeabilization releases RNA that diffuses before capture. Spatial smoothing methods can help reduce noise, but severe background may require protocol optimization.

MERFISH Failure Patterns

Decoding errors are a primary MERFISH failure mode. If the fluorescence signals are weak, overlapping, or noisy, the decoding algorithm may misassign barcodes, producing false transcript identifications. Optimizing probe concentrations, hybridization conditions, and imaging parameters is critical for accurate decoding.

Segmentation errors can misassign transcripts to incorrect cells or exclude transcripts from analysis. Dense tissues with tightly packed cells are particularly challenging for segmentation. Using multiple markers for cell boundaries and validating segmentation against known biology can reduce errors.

Probe panel issues can arise from poor probe design, insufficient specificity, or incomplete coverage of target genes. If your panel includes genes with high sequence similarity, cross-hybridization can produce false signals. Panel validation using control samples with known expression patterns is recommended before large-scale experiments.

Data Analysis Failure Patterns

A common analysis failure is applying inappropriate normalization or dimensionality reduction methods. Spatial data have unique properties, including spatial autocorrelation and varying spot or cell densities, that require methods designed for spatial transcriptomics. Using standard scRNA-seq pipelines without adaptation can produce misleading results.

Over-clustering or under-clustering spatial domains is another common issue. The choice of clustering parameters, including the number of neighbors in the k-nearest-neighbor graph and smoothing parameters, affects the resolution of detected domains. Methods like RASP allow you to explore multiple parameter settings efficiently, which can help you identify robust domain structures.

Records and Documentation

Maintaining detailed records is essential for reproducible spatial transcriptomics experiments and for troubleshooting when problems arise. The documentation burden differs between platforms but the principle is consistent: record enough detail that another researcher could reproduce your experiment and analysis.

Experimental Records

Document the tissue source, preservation method, sectioning parameters, and any fixation or permeabilization conditions. For Visium, record the permeabilization time, cDNA synthesis conditions, and sequencing depth. For MERFISH, record the probe panel design, hybridization conditions, imaging parameters, and decoding settings. These records allow you to compare experiments and identify protocol changes that affect data quality.

Analysis Records

Document the software versions, parameter settings, and reference genome versions used in your analysis. Version control for analysis scripts and pipelines is essential for reproducibility. The Carpentries lessons provide training in version control and reproducible computing practices that are directly applicable to spatial transcriptomics analysis.

Quality Control Records

Record quality control metrics for each sample, including the number of spots or cells passing quality filters, the number of genes detected, and any samples excluded from analysis. These records support transparent reporting and allow you to assess whether quality issues are consistent across experiments.

Statistical Considerations and Power Planning

Statistical power is a critical consideration that is often neglected in spatial transcriptomics experiments. The high cost of data generation makes power planning particularly important for resource allocation.

Power Analysis for Visium

PoweREST provides a framework for estimating statistical power for differential gene expression detection with Visium data. The tool supports power calculations before experiments, using assumptions about effect sizes and variability, and after preliminary data collection, using observed variability. Using PoweREST can help you determine whether your planned number of sections or spots is sufficient to detect biologically meaningful differences between conditions.

The high cost of spatial transcriptomics experiments makes power planning particularly important. Running an underpowered experiment wastes resources and may produce inconclusive results. Running an overpowered experiment wastes resources on unnecessary replicates. Power analysis helps you allocate resources efficiently.

Power Considerations for MERFISH

Power analysis for MERFISH is more complex because the gene panel is fixed and the number of cells detected depends on tissue density and segmentation quality. Pilot experiments can provide estimates of cell counts and expression variability that inform power calculations. The web application provided with PoweREST may be adaptable for MERFISH data, but you should validate its assumptions for your specific panel and tissue type.

Multiple Testing Considerations

Spatial transcriptomics experiments test many genes across many spatial locations, creating substantial multiple testing burdens. Differential expression analysis between conditions should account for spatial autocorrelation, which violates the independence assumption of standard statistical tests. Methods that incorporate spatial information in differential expression testing are preferable to naive approaches.

Integration with Single-Cell and Single-Nucleus Data

Spatial transcriptomics is often combined with single-cell RNA sequencing or single-nucleus RNA sequencing data to overcome the limitations of each platform. This integration strategy is common in practice and requires careful attention to technical differences.

Using scRNA-seq Data for Deconvolution

Visium spot measurements are mixtures of multiple cells, and deconvolution methods use single-cell reference data to estimate cell type proportions in each spot. This approach requires high-quality scRNA-seq or single-nucleus RNA-seq data from the same tissue type. The quality of deconvolution depends on the reference data accurately representing the cell types present in the tissue.

Using scRNA-seq Data for Panel Design

MERFISH panel design can be informed by scRNA-seq data to select genes that distinguish cell types and states. Single-cell data can identify marker genes for each cell population, and these markers can be included in the MERFISH panel. This approach ensures that the panel captures the biological diversity present in your tissue.

Data Integration Challenges

Integrating spatial and single-cell data requires careful attention to batch effects and technical differences between platforms. Single-cell quality control procedures, including filtering low-quality cells and normalizing expression values, should be applied consistently across datasets. Data integration methods can align spatial and single-cell datasets in a shared embedding space, but the results should be validated against known biology.

The NCBI provides access to public single-cell and spatial transcriptomics datasets that can serve as references or validation data. Using public data resources can help you benchmark your analysis pipeline and validate your findings against independent measurements.

Limitations and Interpretation Boundaries

Both platforms have limitations that affect the conclusions you can draw from the data. Recognizing these boundaries prevents overinterpretation and guides appropriate follow-up experiments.

Visium Limitations

The spot resolution of Visium means that measurements are mixtures of cell types. Deconvolution can estimate cell type proportions, but these estimates are uncertain, particularly for rare cell types or cells with similar expression profiles. You cannot draw conclusions about individual cell states or cell-to-cell variability from Visium data alone.

Visium detects only polyadenylated mRNA, excluding non-coding RNAs that lack poly-A tails. The capture efficiency varies by gene and tissue, and lowly expressed genes may not be detected. The 55 micrometer spots also average over subcellular heterogeneity, obscuring any spatial organization within spots.

MERFISH Limitations

The gene panel is the primary limitation of MERFISH. You can only measure the genes you chose, and you cannot discover new genes or isoforms. If your panel misses a relevant gene, you will not detect its expression, and this absence may be misinterpreted as lack of expression.

MERFISH detection efficiency varies by gene and depends on probe design and hybridization conditions. Some transcripts may be missed due to secondary structure or incomplete probe binding. The imaging approach also has limited multiplexing capacity, and very large panels require more imaging rounds, increasing cost and complexity.

Interpretation Boundaries

Spatial transcriptomics measures RNA expression, not protein abundance or activity. Post-transcriptional regulation can decouple RNA and protein levels, and you should not infer protein function directly from RNA measurements. Validation with orthogonal methods, such as immunohistochemistry or in situ protein detection, is recommended for key findings.

Spatial patterns can arise from technical artifacts as well as biology. Tissue processing can create gradients in RNA quality, and imaging artifacts can create false spatial patterns. Careful quality control and validation of spatial patterns against known biology are essential for reliable interpretation.

Safety and Regulatory Context

Spatial transcriptomics experiments involve standard laboratory safety considerations for tissue handling, chemical reagents, and imaging equipment. Institutional requirements vary, and you should consult your local compliance offices before starting experiments.

Tissue Handling Safety

Human tissue samples require appropriate biosafety precautions, including handling under certified biosafety cabinets when infectious agents may be present. Institutional biosafety committees and institutional review boards may require approval for human tissue studies. Animal tissue experiments require institutional animal care and use committee approval.

Chemical Safety

Visium and MERFISH protocols use chemicals that require appropriate handling, including fixatives, organic solvents, and fluorescent dyes. Material safety data sheets should be reviewed, and personal protective equipment should be used as specified. Waste disposal should follow institutional guidelines for chemical and biological waste.

Data Management and Privacy

Spatial transcriptomics data from human samples may contain sensitive information, and data sharing should comply with institutional and regulatory requirements. De-identification of samples and careful data management practices protect patient privacy. The NCBI provides data submission guidelines that include privacy and consent considerations for human genomic data.

Professional Escalation Criteria

Knowing when to seek expert help can save time and resources. The criteria below define situations where consultation with specialists is warranted.

When to Consult a Bioinformatics Specialist

If your analysis pipeline produces inconsistent results across replicates, or if clustering and domain detection results do not match expected tissue biology, consult a bioinformatics specialist. Spatial transcriptomics analysis requires specialized expertise, and standard scRNA-seq pipelines may not be appropriate.

If you are planning a large-scale study with multiple tissue sections or conditions, consult a biostatistician early in the planning process. Power analysis and experimental design are critical for detecting meaningful differences, and statistical expertise can prevent costly design errors.

When to Consult a Platform Specialist

If your Visium experiments consistently show low RNA capture or poor spatial patterns despite protocol optimization, consult the platform vendor or an experienced user. Permeabilization optimization can be challenging, and expert guidance can identify issues that are not obvious from standard troubleshooting.

If your MERFISH experiments show high background fluorescence, poor decoding accuracy, or inconsistent cell segmentation, consult the platform vendor or an experienced imaging specialist. Image processing issues can be subtle, and expert advice can prevent wasted experiments.

When to Escalate to Institutional Resources

If you lack the computational infrastructure for MERFISH data analysis, consult your institutional high-performance computing center before starting experiments. The storage and processing requirements for MERFISH data are substantial, and planning for these resources early is essential.

If you are uncertain about regulatory requirements for human tissue studies or data sharing, consult your institutional review board or research compliance office before starting experiments.

Cost Considerations and Resource Allocation

The cost of spatial transcriptomics experiments varies substantially between platforms and should be considered in the context of your research budget. Direct costs include reagents and instrument time, while indirect costs include personnel training and computational infrastructure.

Visium Cost Structure

Visium costs include the capture slides, library preparation reagents, and sequencing. The sequencing cost depends on the number of sections and the desired sequencing depth. Multiple sections can be multiplexed in a single sequencing run, reducing per-section costs. The analysis costs are primarily computational, and standard workstations can handle most Visium datasets.

MERFISH Cost Structure

MERFISH costs include the probe panel synthesis, imaging reagents, and instrument access. The probe panel is a significant upfront cost, and the cost scales with the number of genes in the panel. Imaging reagents and instrument time add to the per-experiment cost. The computational costs for image processing and storage can be substantial, particularly for large datasets.

Cost-Effectiveness Considerations

For discovery studies where you need transcriptome-wide coverage, Visium is generally more cost-effective because it captures all genes without preselection. For hypothesis-driven studies where you know the relevant genes, MERFISH can be more cost-effective because you only measure the genes you need, and the single-cell resolution may reduce the need for follow-up experiments.

The cost of failed experiments should also be considered. Visium experiments can fail due to permeabilization issues, while MERFISH experiments can fail due to decoding or segmentation problems. The cost of optimization experiments should be included in your budget planning.

Frequently Asked Questions

What is the main difference between Visium and MERFISH resolution?

Visium measures gene expression in 55 micrometer spots that contain multiple cells, producing a mixed expression profile per spot. MERFISH images individual RNA molecules at subcellular resolution, allowing you to assign transcripts to individual cells through image segmentation. This difference determines whether you can study single-cell variability or must rely on computational deconvolution to estimate cell type proportions.

Can I use Visium data to identify individual cell types?

Visium data cannot directly identify individual cells because each spot contains multiple cells. You can estimate cell type proportions using computational deconvolution with single-cell reference data, but these estimates are uncertain, particularly for rare cell types. For direct single-cell identification, MERFISH or other single-cell resolution platforms are necessary.

How many genes can I measure with MERFISH?

The number of genes in a MERFISH panel depends on the barcode design and the number of imaging rounds. Standard panels range from 100 to 500 genes, with newer configurations supporting several thousand genes. The panel must be designed before the experiment, and you cannot discover new genes without designing a new panel.

Does Visium capture the entire transcriptome?

Visium captures polyadenylated mRNA across the transcriptome without preselection. The number of genes detected per spot depends on tissue quality, permeabilization efficiency, and sequencing depth, typically ranging from 2,000 to 5,000 genes per spot. Non-polyadenylated RNAs are not captured.

What computational resources do I need for MERFISH data analysis?

MERFISH data analysis requires substantial computational resources due to the large image datasets, which can exceed several terabytes per experiment. You need high-capacity storage, high-performance computing for image processing and decoding, and specialized software for cell segmentation and transcript assignment. If your institution lacks these resources, MERFISH may not be practical.

How do I plan the number of Visium sections for adequate statistical power?

PoweREST is a power estimation tool designed for Visium data that supports power calculations before experiments and after preliminary data collection. It provides a web application for interactive calculation and visualization. Using PoweREST can help you determine the number of sections or spots needed to detect differentially expressed genes between conditions.

Can I combine Visium data with single-cell RNA sequencing data?

Yes, combining Visium with single-cell RNA sequencing or single-nucleus RNA sequencing data is a common approach. Single-cell data can serve as a reference for deconvolving Visium spots into cell type proportions, and it can inform MERFISH panel design by identifying marker genes. Data integration methods can align spatial and single-cell datasets in a shared embedding space.

What are the main quality control steps for Visium data?

Visium quality control includes assessing sequencing metrics such as read depth per spot, fraction of reads mapped to the transcriptome, and fraction of reads assigned to spatial barcodes. Low-quality spots with few detected genes or high mitochondrial content should be flagged. You should also verify that known cell type markers show appropriate spatial patterns, which can reveal permeabilization or tissue quality issues.

Related Bioinformatics Guides

• Spatial Transcriptomics Data Analysis: A Guide to Preprocessing, Integration, and Interpretation
• Spatial Transcriptomics Workflow: From Sample Preparation to Data Analysis
• Spatial Transcriptomics Platforms Compared: Choosing the Right Technology for Your Study
• Spatial Transcriptomics Data Analysis: A Practical Workflow from Raw Data to Biological Insights
• Spatial Transcriptomics Neighborhood Analysis: Tools and Best Practices

Related Clinical & Scientific Guides

• A Practical Guide to Detecting Antimicrobial Resistance Genes in Shotgun Metagenomic Data
• Computational Immunology: Modeling the Immune System
• How to Set Hard Filters for Germline Variant Calling: A Practical Guide to GATK Best Practices

References and Further Reading

• NCBI Data Resources. National Center for Biotechnology Information.
• EMBL-EBI Training. European Bioinformatics Institute.
• Bioconductor. Bioconductor Project.
• Galaxy Training Network. Galaxy Project.
• nf-core Documentation. nf-core.
• The Carpentries Lessons. The Carpentries.
• Randomized Spatial PCA (RASP): A computationally efficient method for dimensionality reduction of high-resolution spatial transcriptomics data.. 2025.
• Computational identification of migrating T cells in spatial transcriptomics data.. 2026.
• JADE: Joint Alignment and Deep Embedding for Multi-Slice Spatial Transcriptomics.. 2025.
• A spatial code governs olfactory receptor choice and aligns sensory maps in the nose and brain.. 2026.
• MaskGraphene: an advanced framework for interpretable joint representation for multi-slice, multi-condition spatial transcriptomics.. 2025.
• PoweREST: Statistical power estimation for spatial transcriptomics experiments to detect differentially expressed genes between two conditions.. 2025.

This article is educational and does not replace validated analysis plans, institutional policy, clinical interpretation, or specialist review.